Ultragenyx Pharmaceutical Inc. (LON:0LIF)
London · Delayed Price · Currency is GBP · Price in USD 28.31
+1.23 (4.53%)
At close: Aug 7, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Mepsevii | 30.35M | Log In | Log In | Log In | Log In | Upgrade |
Mepsevii Growth | 12.44% | Log In | Log In | Log In | Log In | Upgrade |
Crysvita | 134.71M | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Growth | 69.28% | Log In | Log In | Log In | Log In | Upgrade |
Dojolvi | 88.19M | Log In | Log In | Log In | Log In | Upgrade |
Dojolvi Growth | 22.22% | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Collaboration Revenue in Profit-Share Territory | - | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Collaboration Revenue in Profit-Share Territory Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Royalty Revenue in European Territory | - | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Royalty Revenue in European Territory Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Royalty | 274.82M | Log In | Log In | Log In | Log In | Upgrade |
Crysvita Royalty Growth | 23.27% | Log In | Log In | Log In | Log In | Upgrade |
Daiichi Sankyo | - | Log In | Log In | Log In | Log In | Upgrade |
Daiichi Sankyo Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Evkeeza | 32.16M | Log In | Log In | Log In | Log In | Upgrade |
Evkeeza Growth | 495.35% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
North America | 340.46M | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 14.40% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 80.12M | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 61.64% | Log In | Log In | Log In | Log In | Upgrade |
Latin America | 130.71M | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | 67.66% | Log In | Log In | Log In | Log In | Upgrade |
Asia-Pacific | 8.93M | Log In | Log In | Log In | Log In | Upgrade |
Asia-Pacific Growth | - | Log In | Log In | Log In | Log In | Upgrade |